Literature DB >> 31242412

CRISPR-READI: Efficient Generation of Knockin Mice by CRISPR RNP Electroporation and AAV Donor Infection.

Sean Chen1, Sabrina Sun2, Dewi Moonen1, Clancy Lee3, Angus Yiu-Fai Lee4, David V Schaffer5, Lin He6.   

Abstract

Genetically engineered mouse models harboring large sequence insertions or modifications are critical for a wide range of applications including endogenous gene tagging, conditional knockout, site-specific transgene insertion, and gene replacement; however, existing methods to generate such animals remain laborious and costly. To address this, we developed an approach called CRISPR-READI (CRISPR RNP electroporation and AAV donor infection), combining adeno-associated virus (AAV)-mediated HDR donor delivery with Cas9/sgRNA RNP electroporation to engineer large site-specific modifications in the mouse genome with high efficiency and throughput. We successfully targeted a 774 bp fluorescent reporter, a 2.1 kb CreERT2 driver, and a 3.3 kb expression cassette into endogenous loci in both embryos and live mice. CRISPR-READI is applicable to most widely used knockin schemes requiring donor lengths within the 4.9 kb AAV packaging capacity. Altogether, CRISPR-READI is an efficient, high-throughput, microinjection-free approach for sophisticated mouse genome engineering with potential applications in other mammalian species.
Copyright © 2019. Published by Elsevier Inc.

Entities:  

Keywords:  AAV; CRISPR; CRISPR-EZ; HDR editing; electroporation; genome editing; knockin; mouse models

Mesh:

Substances:

Year:  2019        PMID: 31242412      PMCID: PMC6693498          DOI: 10.1016/j.celrep.2019.05.103

Source DB:  PubMed          Journal:  Cell Rep            Impact factor:   9.423


  59 in total

Review 1.  Self-complementary AAV vectors; advances and applications.

Authors:  Douglas M McCarty
Journal:  Mol Ther       Date:  2008-08-05       Impact factor: 11.454

2.  Heritable gene targeting in the mouse and rat using a CRISPR-Cas system.

Authors:  Dali Li; Zhongwei Qiu; Yanjiao Shao; Yuting Chen; Yuting Guan; Meizhen Liu; Yongmei Li; Na Gao; Liren Wang; Xiaoling Lu; Yongxiang Zhao; Mingyao Liu
Journal:  Nat Biotechnol       Date:  2013-08       Impact factor: 54.908

3.  Rapid generation of inducible mouse mutants.

Authors:  Jost Seibler; Branko Zevnik; Birgit Küter-Luks; Susanne Andreas; Heidrun Kern; Thomas Hennek; Anja Rode; Cornelia Heimann; Nicole Faust; Gunther Kauselmann; Michael Schoor; Rudolf Jaenisch; Klaus Rajewsky; Ralf Kühn; Frieder Schwenk
Journal:  Nucleic Acids Res       Date:  2003-02-15       Impact factor: 16.971

4.  Human gene targeting by viral vectors.

Authors:  D W Russell; R K Hirata
Journal:  Nat Genet       Date:  1998-04       Impact factor: 38.330

5.  High AAV vector purity results in serotype- and tissue-independent enhancement of transduction efficiency.

Authors:  E Ayuso; F Mingozzi; J Montane; X Leon; X M Anguela; V Haurigot; S A Edmonson; L Africa; S Zhou; K A High; F Bosch; J F Wright
Journal:  Gene Ther       Date:  2009-12-03       Impact factor: 5.250

6.  Adeno-associated virus terminal repeat (TR) mutant generates self-complementary vectors to overcome the rate-limiting step to transduction in vivo.

Authors:  D M McCarty; H Fu; P E Monahan; C E Toulson; P Naik; R J Samulski
Journal:  Gene Ther       Date:  2003-12       Impact factor: 5.250

7.  Delivery of Cas9 Protein into Mouse Zygotes through a Series of Electroporation Dramatically Increases the Efficiency of Model Creation.

Authors:  Wenbo Wang; Peter M Kutny; Shannon L Byers; Charles J Longstaff; Michael J DaCosta; Changhong Pang; Yingfan Zhang; Robert A Taft; Frank W Buaas; Haoyi Wang
Journal:  J Genet Genomics       Date:  2016-03-08       Impact factor: 4.275

8.  Electroporation enables the efficient mRNA delivery into the mouse zygotes and facilitates CRISPR/Cas9-based genome editing.

Authors:  Masakazu Hashimoto; Tatsuya Takemoto
Journal:  Sci Rep       Date:  2015-06-11       Impact factor: 4.379

9.  Efficient generation of Rosa26 knock-in mice using CRISPR/Cas9 in C57BL/6 zygotes.

Authors:  Van Trung Chu; Timm Weber; Robin Graf; Thomas Sommermann; Kerstin Petsch; Ulrike Sack; Pavel Volchkov; Klaus Rajewsky; Ralf Kühn
Journal:  BMC Biotechnol       Date:  2016-01-16       Impact factor: 2.563

10.  i-GONAD: a robust method for in situ germline genome engineering using CRISPR nucleases.

Authors:  Masato Ohtsuka; Masahiro Sato; Hiromi Miura; Shuji Takabayashi; Makoto Matsuyama; Takayuki Koyano; Naomi Arifin; Shingo Nakamura; Kenta Wada; Channabasavaiah B Gurumurthy
Journal:  Genome Biol       Date:  2018-02-26       Impact factor: 13.583

View more
  22 in total

1.  AAV6 Is Superior to Clade F AAVs in Stimulating Homologous Recombination-Based Genome Editing in Human HSPCs.

Authors:  Amanda M Dudek; Matthew H Porteus
Journal:  Mol Ther       Date:  2019-09-12       Impact factor: 11.454

2.  Adeno-Associated Virus and Hematopoietic Stem Cells: The Potential of Adeno-Associated Virus Hematopoietic Stem Cells in Genetic Medicines.

Authors:  Saswati Chatterjee; Venkatesh Sivanandam; Kamehameha Kai-Min Wong
Journal:  Hum Gene Ther       Date:  2020-05       Impact factor: 5.695

Review 3.  CRISPR in cancer biology and therapy.

Authors:  Alyna Katti; Bianca J Diaz; Christina M Caragine; Neville E Sanjana; Lukas E Dow
Journal:  Nat Rev Cancer       Date:  2022-02-22       Impact factor: 60.716

4.  A mouse-specific retrotransposon drives a conserved Cdk2ap1 isoform essential for development.

Authors:  Andrew J Modzelewski; Wanqing Shao; Jingqi Chen; Angus Lee; Xin Qi; Mackenzie Noon; Kristy Tjokro; Gabriele Sales; Anne Biton; Aparna Anand; Terence P Speed; Zhenyu Xuan; Ting Wang; Davide Risso; Lin He
Journal:  Cell       Date:  2021-10-12       Impact factor: 41.582

5.  Temporal resolution of gene derepression and proteome changes upon PROTAC-mediated degradation of BCL11A protein in erythroid cells.

Authors:  Stuti Mehta; Altantsetseg Buyanbat; Yan Kai; Ozge Karayel; Seth Raphael Goldman; Davide Seruggia; Kevin Zhang; Yuko Fujiwara; Katherine A Donovan; Qian Zhu; Huan Yang; Behnam Nabet; Nathanael S Gray; Matthias Mann; Eric S Fischer; Karen Adelman; Stuart H Orkin
Journal:  Cell Chem Biol       Date:  2022-07-14       Impact factor: 9.039

Review 6.  CRISPR-Cas9-Based Technology and Its Relevance to Gene Editing in Parkinson's Disease.

Authors:  Mujeeb Ur Rahman; Muhammad Bilal; Junaid Ali Shah; Ajeet Kaushik; Pierre-Louis Teissedre; Małgorzata Kujawska
Journal:  Pharmaceutics       Date:  2022-06-13       Impact factor: 6.525

7.  Development of an in vivo cleavable donor plasmid for targeted transgene integration by CRISPR-Cas9 and CRISPR-Cas12a.

Authors:  Riki Ishibashi; Ritsuko Maki; Satsuki Kitano; Hitoshi Miyachi; Fumiko Toyoshima
Journal:  Sci Rep       Date:  2022-10-22       Impact factor: 4.996

8.  AAV diffuses across zona pellucida for effortless gene delivery to fertilized eggs.

Authors:  Charles Romeo; Shih-Heng Chen; Eugenia Goulding; Lucas Van Gorder; Maura Schwartz; Mitzie Walker; Gregory Scott; Erica Scappini; Manas Ray; Negin P Martin
Journal:  Biochem Biophys Res Commun       Date:  2020-03-17       Impact factor: 3.575

Review 9.  Modulation of DNA double-strand break repair as a strategy to improve precise genome editing.

Authors:  Ujjayinee Ray; Sathees C Raghavan
Journal:  Oncogene       Date:  2020-09-03       Impact factor: 9.867

Review 10.  Homology-based repair induced by CRISPR-Cas nucleases in mammalian embryo genome editing.

Authors:  Xiya Zhang; Tao Li; Jianping Ou; Junjiu Huang; Puping Liang
Journal:  Protein Cell       Date:  2021-05-04       Impact factor: 14.870

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.